Pain and neurodiversity in refractory rheumatoid arthritis patients

  • Research type

    Research Study

  • Full title

    Characterizing neuroinflammatory and psychological correlates in refractory rheumatoid arthritis patients

  • IRAS ID

    321871

  • Contact name

    Lucy Zhao

  • Contact email

    lucy.zhao@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    1 years, 7 months, 30 days

  • Research summary

    Rheumatoid arthritis (RA) is the most prevalent form of inflammatory arthritis. In refractory RA, pain, a dominating symptom, is poorly described, and under treated. The underlying mechanisms involved are regulated by higher brain structures responsible for our emotional and cognitive states1. Therefore, it is thought that atypical changes in these regions (e.g., neurodivergent traits associated with depression, anxiety, autism, or ADHD) can influence the way we perceive pain, therefore contributing to the development of chronic pain. However, despite their significant relevance in RA and refractory disease activity, neither pain nor neurodiversity/mental health components have been appropriately assessed in the clinic or in research. We aim to address this unmet need.
    To investigate how pain manifests in refractory RA, to include the influence psychological factors have on the pain experience and disease activity, our aim, in refractory RA patients, is to 1) generate sensory profiles using quantitative sensory testing (QST); 2) assess neurodiversity profiles using mental health questionnaires, and 3) evaluate disease activity by using clinical reports and measuring inflammatory biomarkers in blood samples. In doing so, we aim to establish a bedside protocol that will help clinicians consolidate an appropriate classification of the disease state, providing patients with personalized therapeutic strategies.

  • REC name

    London - Hampstead Research Ethics Committee

  • REC reference

    24/LO/0046

  • Date of REC Opinion

    31 Jan 2024

  • REC opinion

    Further Information Favourable Opinion